[go: up one dir, main page]

ES2159838T3 - Derivados de ergolina heterociclicos como ligandos del receptor de 5ht1a. - Google Patents

Derivados de ergolina heterociclicos como ligandos del receptor de 5ht1a.

Info

Publication number
ES2159838T3
ES2159838T3 ES97903245T ES97903245T ES2159838T3 ES 2159838 T3 ES2159838 T3 ES 2159838T3 ES 97903245 T ES97903245 T ES 97903245T ES 97903245 T ES97903245 T ES 97903245T ES 2159838 T3 ES2159838 T3 ES 2159838T3
Authority
ES
Spain
Prior art keywords
heterociclic
group
5ht1a
ergoline derivatives
nitrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97903245T
Other languages
English (en)
Inventor
Sergio Mantegani
Tiziano Bandiera
Maurizio Meroni
Mario Varasi
Carla Caccia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pharmacia and Upjohn SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn SpA filed Critical Pharmacia and Upjohn SpA
Application granted granted Critical
Publication of ES2159838T3 publication Critical patent/ES2159838T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

LOS DERIVADOS DE ERGOLINA QUE TIENEN LA FORMULA (I), EN LA QUE R 1 ES UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO C SUB,1-4 ; R 2 ES HIDROGENO, UN ATOMO DE CLORO, O BROMO, MET ILO O UN GRUPO TIOALQUILO C 1-4 ; N ES 0, 1 O 2; EL SUSTITUYENTE EN LA POSICION 8 ESTA EN CONFIGURACION AL O BE ; HET REPRESENTA UN ANILLO HETEROCICLICO DE 5 ESLABONES AROMATICO, TENIENDO DICHO ANILLO TRES HETEROATOMOS , LOS CUALES SON IGUALES O DIFERENTES Y SE SELECCIONAN ENTRE EL GRUPO QUE CONSISTE EN UN ATOMO DE AZUFRE, OXIGENO Y NITROGENO Y X ES UN ATOMO DE HIDROGENO, CLORO, BROMO O FLUORO O UNA SAL DE ADICION DE ACIDO FARMACEUTICAMENTE ACEPTABLE DE LOS MISMOS, SON ACTIVOS A NIVEL DEL SISTEMA NERVIOSO CENTRAL. TAMBIEN SE DESCRIBE UN PROCEDIMIENTO PARA SU PREPARACION, ASI COMO LAS COMPOSICIONES FARMACEUTICAS QUE LAS CONTIENEN.
ES97903245T 1996-02-15 1997-02-07 Derivados de ergolina heterociclicos como ligandos del receptor de 5ht1a. Expired - Lifetime ES2159838T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9603226.3A GB9603226D0 (en) 1996-02-15 1996-02-15 Heterocyclyl-ergoline derivatives

Publications (1)

Publication Number Publication Date
ES2159838T3 true ES2159838T3 (es) 2001-10-16

Family

ID=10788832

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97903245T Expired - Lifetime ES2159838T3 (es) 1996-02-15 1997-02-07 Derivados de ergolina heterociclicos como ligandos del receptor de 5ht1a.

Country Status (26)

Country Link
US (1) US6087371A (es)
EP (1) EP0885222B1 (es)
JP (1) JP2000504700A (es)
KR (1) KR19990082680A (es)
CN (1) CN1211253A (es)
AR (1) AR005820A1 (es)
AT (1) ATE201683T1 (es)
AU (1) AU1767797A (es)
BR (1) BR9707463A (es)
CA (1) CA2243992A1 (es)
DE (1) DE69705032T2 (es)
DK (1) DK0885222T3 (es)
EA (1) EA199800720A1 (es)
ES (1) ES2159838T3 (es)
GB (1) GB9603226D0 (es)
GR (1) GR3036390T3 (es)
HU (1) HUP9900572A3 (es)
IL (1) IL125344A0 (es)
MX (1) MX9806341A (es)
NO (1) NO983656L (es)
NZ (1) NZ331087A (es)
PL (1) PL328373A1 (es)
PT (1) PT885222E (es)
TW (1) TW360655B (es)
WO (1) WO1997030050A1 (es)
ZA (1) ZA971167B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1685838A1 (en) * 2000-08-16 2006-08-02 Pharmacia & Upjohn Company LLC Compounds for the treatment of addictive disorders
MXPA03001472A (es) * 2000-08-16 2003-06-06 Upjohn Co Compuestos para el tratamiento de trastornos adictivos.
US8106074B2 (en) 2001-07-13 2012-01-31 Pierre Fabre Medicament Pyridin-2-yl-methylamine derivatives for treating opiate dependence
EP2583557B1 (de) * 2008-07-17 2016-01-13 Bayer CropScience AG Heterocyclische Verbindungen als Schädlingsbekämpfungsmittel
CN106866656A (zh) * 2017-02-28 2017-06-20 西南交通大学 一类麦角碱衍生物及其在预防和治疗精神疾病的用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU39278B (en) * 1976-12-22 1984-10-31 Lek Tovarna Farmacevtskih Process for preparing 5-bromo nicotinic acid esters
GB8714767D0 (en) * 1987-06-24 1987-07-29 Erba Farmitalia Egoline derivatives
AU553809B2 (en) * 1981-07-21 1986-07-31 Farmitalia Carlo Erba S.P.A. Ergoline derivatives
HU190105B (en) * 1983-06-03 1986-08-28 Gyogyszerkutato Intezet Process for production of pirazolyl-methyl-ergolin- derivatives and their acid additional salts
HU193781B (en) * 1985-06-21 1987-11-30 Richter Gedeon Vegyeszet Process for producing 10alpha-methoxy-6-methylergoline derivatives and acid additional salts thereof
GB8612366D0 (en) * 1986-05-21 1986-06-25 Erba Farmitalia Ergoline esters
GB8702364D0 (en) * 1987-02-03 1987-03-11 Erba Farmitalia Ergolinyl heterocycles
DE3868866D1 (de) * 1987-11-20 1992-04-09 Erba Carlo Spa Ergolinderivate mit antiparkinsonwirkung.
CA2049053A1 (en) * 1990-01-25 1991-07-26 Sergio Mantegani Process for preparing ergoline derivatives
JP2888648B2 (ja) * 1990-12-28 1999-05-10 出光興産株式会社 スチレン系重合体の製造方法及びその触媒

Also Published As

Publication number Publication date
DE69705032T2 (de) 2001-11-22
HUP9900572A3 (en) 2000-10-30
ZA971167B (en) 1997-08-25
EA199800720A1 (ru) 1999-02-25
NO983656L (no) 1998-10-12
BR9707463A (pt) 1999-07-20
GR3036390T3 (en) 2001-11-30
AU1767797A (en) 1997-09-02
US6087371A (en) 2000-07-11
CA2243992A1 (en) 1997-08-21
KR19990082680A (ko) 1999-11-25
ATE201683T1 (de) 2001-06-15
DE69705032D1 (de) 2001-07-05
EP0885222B1 (en) 2001-05-30
HUP9900572A2 (hu) 1999-06-28
IL125344A0 (en) 1999-03-12
JP2000504700A (ja) 2000-04-18
PT885222E (pt) 2001-10-31
MX9806341A (es) 1998-10-31
NZ331087A (en) 1999-08-30
AR005820A1 (es) 1999-07-14
WO1997030050A1 (en) 1997-08-21
TW360655B (en) 1999-06-11
CN1211253A (zh) 1999-03-17
PL328373A1 (en) 1999-01-18
NO983656D0 (no) 1998-08-10
DK0885222T3 (da) 2001-08-27
GB9603226D0 (en) 1996-04-17
EP0885222A1 (en) 1998-12-23

Similar Documents

Publication Publication Date Title
ES2174579T3 (es) Nuevos derivados benzotiofenicos, benzofuranicos e indolicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES2157224T3 (es) Derivados de 5-arilindol y su uso como agonistas de serotonina (5-ht 1).
ES2195121T3 (es) Uso de una sal farmaceuticamente aceptable de (3r,2'r)-3-((ciclopentilhidroxifenilacetil)oxi)-1,1-dimetilpirrolidinio para la preparacion de un medicamento.
CA2339630A1 (en) Carboline derivatives as cgmp phosphodiesterase inhibitors
ES2162188T3 (es) Procedimiento para la preparacion de derivados de imidazol, triazol y tetrazol y su uso como agonistas selectivos de receptores 5-ht-1.
AP9600817A0 (en) Novel cryatal form of anhydrous 7-( [1A,5A,6A]-6-amino3-3-azabicyclo [3.1.0.] hex-3-yl) -6-fluro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1, 8-naphthyridine-3-carboxylic acid, methanesulfonic acid salt.
HUT77667A (hu) Imidazo[4,5-c]kinolin-aminok, ezeket tartalmazó gyógyászati készítmények, és alkalmazásuk
NO20065995L (no) Mikropartikler
BR0212864A (pt) Derivados de 1,6-naftiridina como antidiabéticos
ECSP941156A (es) 3 bencilaminometil piperidinas substituidas con heteroarilamino y heteroarilsulfonamido y compuestos afines
HUT68251A (en) Antiviral 2-ethyl-1h-imidazo(4,5-c)quinolin-4-amines and pharmaceutical compositions containing them
DE60017582D1 (de) Tricyclische derivate der pyrazolcarbonsäure, ihre herstellung und sie enthaltende pharmazeutische zubereitungen
ES2150918T3 (es) 1h-imidazo(4,5-c)quinolin-4-aminas 1-sustituidas; compuestos intermedios y composiciones farmaceuticas.
ES2064973T3 (es) Nuevos derivados de indol.
ES2054872T3 (es) Nuevos derivados de acido bencimidazolin-2-oxo-1-carboxilico utiles como antagonistas de los receptores 5-ht.
ES2159838T3 (es) Derivados de ergolina heterociclicos como ligandos del receptor de 5ht1a.
AR002753A1 (es) El acido 7-([1 alfa,5 alfa,6 alfa]-6-amino-3-azabiciclo[3.1.0]hex-3-il)-6- fluor-1-(2,4-difluorofenil)-1,4-didhiro-4-oxo-1,8-naftiridin-3-carboxilico, saldel acido metanosulfonico, un procedimiento para prepararla y una composicion farmaceutica con actividad bacteriana que la comprende
DE69131759D1 (de) An den Positionen 2 und 9 substituierte 4H-pyrido-(1,2-a)pyrimidin-4-one
AR038620A1 (es) Derivados de 1-(alquil), 1-((heteroaril)alquil) y 1-((aril) alquil)-7-(pirimidin-4-il)-imidazo(1,2-a)pirimidin-5(1h)-ona
CA2155323A1 (en) Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof
ES2045189T3 (es) Nuevos agentes anti-arritmicos i.
WO1992022527A3 (en) 3-substituted pyrrolidine derivatives as calcium channel antagonists
YU31592A (sh) 6-HETEROCIKLIČNI-4-AMINO-1,2,2a,3,4,5- HEKSAHIDROBENZ (cd) INDOLI
MX9806229A (es) Derivados de benzo(c)quinolicina, su preparacion y uso como inhibidores de la 5alfa-reductasas.
JPS6466116A (en) Antiemetic containing specific substituted phenylalkylamino and amino acid derivatives and compound selected from other serotonin drying drugs

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 885222

Country of ref document: ES